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Homeostatic cardiac function is maintained by a complex network of interdependent
signaling pathways which become compromised during disease progression.
Excitation-contraction-coupling, the translation of an electrical signal to a contractile
response is critically dependent on a tightly controlled sequence of events culminating in
a rise in intracellular Ca2+ and subsequent contraction of the myocardium. Dysregulation
of this Ca2+ handling system as well as increases in the production of reactive oxygen
species (ROS) are two major contributing factors to myocardial disease progression.
ROS, generated by cellular oxidases and by-products of cellular metabolism, are highly
reactive oxygen derivatives that function as key secondary messengers within the
heart and contribute to normal homeostatic function. However, excessive production of
ROS, as in disease, can directly interact with kinases critical for Ca2+ regulation. This
post-translational oxidative modification therefore links changes in the redox status of
the myocardium to phospho-regulated pathways essential for its function. This review
aims to describe the oxidative regulation of the Ca2+/calmodulin-dependent kinase II
(CaMKII) and cAMP-dependent protein kinase A (PKA), and the subsequent impact this
has on Ca2+ handling within the myocardium. Elucidating the impact of alterations in
intracellular ROS production on Ca2+ dynamics through oxidative modification of key
ROS sensing kinases, may provide novel therapeutic targets for preventing myocardial
disease progression.
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ROS-sources and Function
The sequential reduction of molecular oxygen leads to formation of biological forms of ROS
comprising of the superoxide anion (O−2 ), hydrogen peroxide (H2O2) and hydroxyl radical
(HO•).These forms of ROS are capable of altering cellular signaling by modifying susceptible
proteins. Initially thought to contribute solely to cellular damage it has become clear that
ROS signaling pathways are in fact a highly organized and compartmentalized network critical
for homeostatic biological function (Wu et al., 2010; Datla et al., 2014). For example ROS
produced by nicotinamide adenine dinucleotide phosphate-oxidase (NOX) enzymes modulate
cardiac transcription factors, cell migration, vascular tone, and cardiac contraction (Aslan and
Ozben, 2003; Clempus et al., 2007; Burgoyne et al., 2012). However, their excessive production,
both transiently, and chronically, are now implicated in numerous cardiovascular pathologies such
as inflammation, arrhythmias, diabetes, hypertension, atherosclerosis, reperfusion injury, fibrosis,
Johnston et al. Redox regulation of PKA/CaMKII within the myocardium
and diastolic dysfunction (Higashi et al., 2002; Fortuño et al.,
2004; Zweier and Talukder, 2006; Birukov, 2009; Frantz et al.,
2009; Giacco and Brownlee, 2010; Prysyazhna et al., 2012;
Wagner et al., 2013; Murdoch et al., 2014).
Mitochondria are a major source of intracellular ROS
generation due to leakage of electrons from the electron transport
chain that react with molecular oxygen to generate superoxide.
Once generated, the superoxide is readily converted to more
stable H2O2 by the enzyme superoxide dismutase (SOD).
Importantly, as mitochondrial complexes are abundant in heme
groups and iron sulfur clusters H2O2 can also be converted to
highly reactive hydroxyl radicals (Carroll et al., 2006; Chen and
Zweier, 2014). In addition to ROS generated by the electron
transport chain enzymatic networks such as NOX, xanthine
oxidase and uncoupled nitric oxide synthases contribute to
endogenous ROS production (Brown and Griendling, 2015).
Homeostatic balance of this system is maintained through both
enzymatic (SOD, catalase, glutathione peroxidase) and non-
enzymatic [vitamins, thioredoxin (TRX), flavonoids] scavenging
systems. Under normal homeostatic conditions this system
is tightly balanced such that moderate increases in ROS
can act as secondary messengers by reversibly modifying
protein function. However, during disease states when ROS are
excessively produced or when exogenously applied to mimic
excess production, the innate anti-oxidant scavenging system
becomes overwhelmed. The impact of this imbalance on the
cellular environment is a shift to a state of excessive ROS levels
termed “oxidative stress.”
While in vivo animal models of cardiac pathology have
highlighted redox-balance as a mediator of heart failure
progression the translation of this to a clinical setting is becoming
more apparent. Congestive heart failure progression, dilated,
and ischemic cardiomyopathy, end stage heart failure, chronic
heart failure, and ethanol induced cardiac abnormalities are
all associated with a concurrent rise in free radical generation
(Jaatinen et al., 1993; Landmesser, 2002; Maack et al., 2003;
Giordano, 2005; Kunishige et al., 2007; Nakamura et al., 2015;
Shah, 2015). Additionally, it is emerging that the enzymes
and cellular sources driving increased ROS production may be
divergent depending on the pathology involved such as systolic
vs. diastolic dysfunction (Münzel et al., 2015). However, long
term controlled clinical antioxidant trials principally, using the
antioxidants vitamin E, C, and β-carotene, have failed to find any
evidence of a beneficial effect. In fact in some cases antioxidant
therapy was seen to associate with morbidity and probability
of a cardiac event (Kris-Etherton et al., 2004). While several
hypotheses have been offered to explain this disappointing result
the principal argument has been that exogenous application of
anti-oxidants fails to effectively target discreet molecular sources
of ROS production and may in fact hinder pro-survival oxidant
signaling pathways. Therefore, in order to develop targeted and
effective anti-oxidant therapies it is necessary to understand the
molecular redox signaling pathways involved.
Oxidative Modification of Proteins
The ability of ROS to act as secondary messengers is attributed
to their ability to oxidize susceptible cysteine thiols or sulfur on
methionine residues of select proteins. The alteration of cysteine
or methionine residues by oxidation generates a conjugated
moiety with a different shape and charge characteristic,
which can induce structure rearrangement to alter enzymatic
activity. Protein oxidation is considered a physiological signaling
modality as it can specifically and transiently regulate protein
function. The selectivity of protein oxidation is provided by the
limited reactivity of cysteine thiols. This is due to the majority of
cysteines being buried within proteins and thus not accessible to
an oxidant. In addition the pKa of an accessible cysteine thiol is
an important determinant of its reactivity. For a cysteine thiol to
be sensitive to oxidation it generally needs to be in a deprotonated
“reactive” thiolate anion form (S−) and thus have a low pKa.
The pKa of a cysteine thiol is determined by its local tertiary
environment, which is lowered by close proximity to basic amino
acids lysine, arginine, or histidine.
A major form of ROS responsible for oxidant-dependent
signaling is H2O2 formed enzymatically through the dismutation
of superoxide. Once generated H2O2 readily reacts with cysteine
thiols to form a sulfenic acid (SOH) intermediate, which is then
rapidly resolved by an adjacent cysteine on the same protein
or neighboring protein to form an intra- or inter-molecular
disulfide respectively (Figure 1). Alternatively a sulfenic acid
reacts with the highly replete cellular thiol containing tri-peptide
glutathione (GSH), leading to protein glutathiolation.
Once oxidized a cysteine thiol can be reduced by the replete
cellular reducing system. The rate of reduction and hence
stability of an oxidative modification is determined by its type,
accessibility and the quantity of oxidant present. Formation of
an inter- or intra- molecular disulfide within a target protein
can be reduced by TRX through a disulfide exchange reaction
(Hanschmann et al., 2013). This leads to reduction of the target
protein and oxidation of TRX, which is then recycled back
to its reduced form by TRX reductase and electrons provided
by NADPH. The formation of a glutathione adduct on a
protein is also readily reversible and is enzymatically reduced by
glutaredoxin. However, in contrast to TRX, glutaredoxin does not
have an oxidoreductase and instead uses free GSH to reduce its
target, which leads to formation of oxidized glutathione (GSSG).
A similar mechanism for oxidation and reduction exists for
methionine residues. When H2O2 reacts with methionine this
generates amethionine sulfoxide than can be reduced by the aptly
named methionine sulfoxide reductase (Msr) (Kim, 2013).
Under conditions of excessive oxidant production cysteine
and methionine can transition to irreversibly oxidized states
associated with disease and known as hyperoxidation. A cysteine
sulfenic acid can be further oxidized to a sulfinic (SO2H) and
then to sulfonic acid (SO3H). The formation of a sulfonic acid
is irreversible, whereas a sulfinic acid is only reversible on
peroxiredoxin at the expense of ATP and driven by the enzyme
sulfiredoxin (Biteau et al., 2003). The reversibility of methionine
sulfoxide is lost is the presence of excess H2O2, which leads to
irreversible methionine sulfone formation.
In addition to H2O2 reactive nitrogen species (RNS) also
contribute to thiol-dependent redox signaling by forming protein
nitric oxide (NO) adducts termed S-nitrosylation (SNO). NO
generated from L-arginine by the nitric oxide synthases while
remaining in its native form is unable to directly modify
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FIGURE 1 | Post translational oxidative modification of cysteine
and methionine residues. The gluthathiolation of a cysteine thiol
can be reversibly reduced by glutaredoxin (Grx) while disulfides are
reduced by thioredoxin (Trx). Oxidation of a methionine to the
sulfoxide form can be reduced by methionine sulfoxide reductase A
(MsrA).
cysteine thiols. However, the formation of the nitrosonium
cation (NO+) or dinitrogen trioxide (N2O3) can induce direct
thiol oxidation (N2O3 + RSH → RSNO + HNO2), whereas,
small thiol containing compounds such as S-nitrosoglutathione
(GSNO) can induce protein S-nitrosylation through an exchange
reaction termed trans-nitrosylation (GSNO + RSH→ RSNO +
GSH) (Broniowska and Hogg, 2012). A protein nitrosothiol is
relatively unstable and can therefore act as an intermediate in
the formation of a more stable disulfide in a similar manner to
a sulfenic acid. In situations where there is localized formation
of both nitric oxide and superoxide this can lead to formation of
the highly reactive species peroxynitrite (ONOO−). Peroxynitrite
can induce S-nitrosylation but also irreversible tyrosine nitration
that is often associated with disease.
The oxidative modifications induced by ROS and RNS
account for a large proportion of cellular thiol-dependent redox
signaling. However, this form of signaling is further extended
by the ability of cysteines to be modified by reactive lipids
and natural electrophiles. Thesemodifications are predominantly
dependent on the presence of an alpha-beta unsaturated carbonyl
group that allows nucleophilic addition of a thiol through a
Michael addition reaction. Examples of thiol reactive lipids
include 15-deoxy-112,14-Prostaglandin J2, nitro-oleic acid and
4-hydroxynonenal (Benderdour et al., 2003; Charles et al., 2011,
2014). Natural electrophiles that modify cysteines include the
plant-derived compounds sulforaphane and curcumin (Dinkova-
Kostova et al., 2002; Fang et al., 2005). Each of these thiol-reactive
compounds has a biological effect on signaling dependent on
their ability to modify cysteine thiols. However, even though they
may share similar thiol-reactivity their target selectivity differs
due to each compounds unique charge and shape characteristic,
thus explaining why each has a varying physiological effect.
As well as natural compounds a number of kinase inhibitors
have been developed that target select cysteine thiols. This
includes the ribosomal s6 kinase (RSK) inhibitor FMK and the
transforming growth factor beta-activated kinase 1 inhibitor
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(5Z)-7-oxozeaenol (Cohen et al., 2005; Sogabe et al., 2015). The
use of pharmacological inhibitors that modify a select thiol to
inhibit its respective target provides further credence for protein
oxidation being a selective mode of signaling.
Methods for Detecting Protein Oxidation
The identification and characterization of protein oxidation has
been largely hampered by a lack of direct methods for detection.
Recent developments in novel tools and indirect methods for
detecting protein oxidation have greatly improved the expanding
field of redox biology (Figure 2). Many of these methods rely
on exchange reactions, where the oxidative moiety is reduced
and then swapped for a detectable tag that is usually biotin or
in some cases a fluorophore (Burgoyne and Eaton, 2011). In
this type of method, often referred to as biotin-switch, proteins
(from lysate or homogenate) are firstly alkylated (usually with
N-ethylmaleimide or maleimide) under denaturing conditions
to block any free cysteine thiols. The alkylating reagent is
then removed (usually by desalting), the oxidative moiety of
interest selectively reduced and then these free thiols labeled
with a biotin-tagged alkylating agent that is either modified
maleimide, iodoacetamide, or pyridyldithiol. To examine
S-nitrosylation ascorbate is used to selectively reduce this
modification for labeling. For sulfenic acid formation sodium
arsenite is used as a selective reductant and for total reversibly
oxidized thiols either dithiothreitol, 2-mercaptoethanol or
Tris(2-carboxyethyl)phosphine hydrochloride. Once the
oxidative modification of interest has been exchanged for a
biotin-tag, modified proteins can then be readily detected using
streptavidin-HRP or purified using streptavidin sepharose
and identified using mass spectrometry (Figure 2A). A recent
variation on the biotin-switch assay is labeling oxidized thiols
with maleimide conjugated to a 5 kDa PEG-tag (Burgoyne
et al., 2013). This allows simple and rapid determination of
target oxidation without the need for affinity purification. If a
protein is oxidized it will be labeled following reduction with
PEG-maleimide causing it to resolve at a higher molecular on a
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) gel. A change in the molecular weight of a target protein
can then be determined by immunoblotting using a selective
antibody. In addition to switch-based methods a number of
novel dimedone-based tools have been developed to detect thiol
sulfenic acids (Figure 2D).These methods exploit the specific
reactivity of dimedone for sulfenic acids by using fluorescent and
biotin derivates or antibodies for detection (Charles et al., 2007;
Maller et al., 2011).
To identify novel proteins that form intermolecular disulfide
complexes a method has been developed termed diagonal gel
electrophoresis (Figure 2B) (Burgoyne and Eaton, 2013b). This
method exploits the differential ability of proteins to resolve
on an SDS-PAGE gel in their reduced and disulfide bound
form. Firstly, samples are run under non-reducing conditions
on a standard SDS-PAGE gel. Once fully resolved the lane is
excised, soaked in 2-mercaptoethanol to reduce disulfides and
then placed horizontally onto a new SDS-PAGE gel. This second
gel is resolved and then proteins stained so that they can be
visualized. The concept of this method is that disulfide bound
complexes will resolve at a combined weight on the first gel and
then reduced components at a lower molecular weight on the
second gel. Therefore, any proteins originally in a disulfide bound
complex will run off the diagonal plane of the second resolved
gel. Once visualized any proteins running below the diagonal
plane can be excised and indentified using mass spectrometry.
This method was used to identify the regulatory R1 subunit
of PKA, described below, as a redox-sensitive disulfide dimer
(Brennan et al., 2006). PKARI was identified in an experiment
using diamide to selectively induce disulfide formation in rat
ventricular myocyte proteins before being resolved by diagonal
gel electrophoresis.
Once a target of inter-molecular disulfide complex formation
has been identified it can be readily screened in biological samples
using a selective antibody. In this case tissue or cells should be
lysed or homogenized into alkylating agent to prevent artificial
air oxidation (Burgoyne and Eaton, 2013a). These samples are
then run under non-reducing conditions and western blotted for
the target of interest. If the target protein forms a disulfide bound
complex then it will be detected at a higher molecular weight,
which will be susceptible to reduction by 2-mercaptoethanol
(Figure 2C). Examples of proteins that are known to form
redox-regulated disulfide bound complexes in addition to PKARI
include cyclic guanosine monophosphate (cGMP) dependent
protein kinase 1α (PKG1α), mitsugumin 53, and peroxiredoxin
(Burgoyne et al., 2007; Cai et al., 2009; Rhee and Woo, 2011).
Excitation Contraction Coupling
Cardiac contraction is modulated through the coupling of an
electrical stimulus to a contractile output in a process known
as excitation-contraction coupling (ECC). An action potential
depolarizes the cell membrane activating voltage sensitive L-type
Ca2+ channels (LTCC/Cav1.2) and allowing Ca2+ to flow into the
cell where it binds to cardiac ryanodine receptors (RyR2) on the
adjacent sarcoplasmic reticulum (SR). This binding precipitates
cell-wide Ca2+ release from the sarcoplasmic reticulum (SR)
store termed “Ca2+ induced Ca2+ release” (CICR), giving rise to a
synchronous cardiac contraction. For the myocardium to relax it
is necessary that cytoplasmic Ca2+ levels are returned to diastolic
levels allowing Ca2+ to dissociate from the myofilaments. This is
accomplished through inactivation of extracellular Ca2+ entering
through LTCC and Ca2+ extrusion from the cytoplasm via the
sarcoplasmic reticulum ATPase (SERCA), Na/Ca2+ exchanger,
sarcolemmal Ca2+ ATPase and mitochondrial uniporter (Bers,
2002).
A central tenet to myocardial dysfunction, heart failure
progression and eventual cardiac arrest is the dysregulation of
Ca2+ handling and thus ECC within cardiomyocytes. Following
the development of cardiac or vascular pathology the contractile
requirements of the heart are severely increased in order to
adequately compensate for the diseased tissue. The abundance of
LTCC is reduced and the channel becomes hyperphosphorylated
(Chen, 2002; Lugenbiel et al., 2015), RyR2 are similarly
hyperphosphorylated (Ai et al., 2005; Shan et al., 2010a), SERCA
expression is reduced (Hasenfuss et al., 1994) as is its activity by
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FIGURE 2 | Methods for detecting protein oxidation. (A) The
biotin-switch assay allows reversible oxidative modifications to be
swapped for a detectable biotin-tag. To selectively detect S-nitrosothiol
modified proteins ascorbate is used as a reducant and for sulfenic acids
sodium arsenite. To detect all reversibly oxidized proteins dithiothreitol can
be used as a reductant. (B) Diagonal SDS-PAGE is used to identify
proteins that form intermolecular disulfide bound complexes. In the first
dimension proteins are run under non-reducing conditions to maintain
complexes at their combined disulfide-bound molecular weight. Once
resolved the lane is excised and run on a second gel under reducing
conditions so that disulfide bound proteins can then run at their individual
unbound molecular weight. Once proteins have been resolved and then
stained, those that were originally in a disulfide bound complex can be
observed below the diagonal plane of the gel. These proteins can be
identified by excising and then analysing by mass spectrometry. (C)
Proteins already known to form intermolecular disulfide bound complexes
or identified by diagonal SDS-PAGE can be analyzed in cell or tissue
samples for covalent complex formation by resolving under non-reducing
conditions. By omitting the reducing agent disulfide bound complexes are
preserved and can be detected as a higher molecular weight complex on
immunostained blots. The formation of higher molecular weight
complexes will increase under oxidizing conditions due to enhanced
disulfide formation and will be reducible with 2-mecaptoethanol. (D)
Cysteine sulfenic acids can be detected by the addition of dimedone, as
it is able to selectively bind to this modification. Fluorescent or biotin
derivates of dimedone can be used for detection or purification of sulfenic
acid modified proteins. Alternatively a dimedone specific antibody can be
used for detecting this compound when bound to protein sulfenic acids.
hypo-phosphorylation of phospholamban (PLB) (Reiken et al.,
2003) while NCX extrusion of Ca2+ is increased (Lugenbiel et al.,
2015). The net impact of this, as seen in myocytes from failing
hearts, is a reduced ability to drive Ca2+ into the cytoplasm and
SR, therefore limiting Ca2+ release during systole and increasing
its accumulation during diastole. Reduced systolic Ca2+ levels
impair cardiac inotropy while its diastolic accumulation, through
leak and inadequate re-uptake, is arrhythmogenic due to
its extrusion via the electrogenic NCX which introduces a
depolarizing current to the myocyte during diastole (Bers, 2014).
Therefore, the failing myocardium must increase its contractile
output in spite of a reduction in the basic machinery necessary
to achieve this, and so the shift toward decompensated heart
failure begins. It has become clear that aberrant oxidative-
modification of proteins by excessive ROS production also
contributes to dysfunctional Ca2+ handling and contractility in
heart failure. As such any therapy aimed at correcting contractile
abnormalities must also address specific redox signaling
events.
Heart failure is associated with a shift in the redox
environment of the heart to a pro-oxidative state. Although,
there is evidence for a reduction in the antioxidant capacity of
the heart during disease, the principal driving force toward this
pro-oxidative milieu appears to be excessive ROS production
(Landmesser, 2002; Maack et al., 2003; Giordano, 2005;
Kunishige et al., 2007; Nakamura et al., 2015). To investigate the
physiological consequence of this on the contractile ability of
the myocardium, cardiomyocytes have been exposed to various
forms of ROS, had oxidant formation inhibited or applied with
exogenous anti-oxidants. Exposure of cardiomyocytes to H2O2,
O−2 and HO
• decrease Ca2+ transient amplitude, SR Ca2+
content and SR Ca2+ re-uptake, indices that mimic that observed
in the failing heart (Gill et al., 1995; Xu et al., 1998; Fearon et al.,
1999). Additionally, counterbalancing ROS production through
targeting of its sources or the application of anti-oxidants reverses
contractile dysfunction (Shiomi et al., 2004; Guo et al., 2006;
Gonzalez et al., 2007; Qin et al., 2007; Saliaris et al., 2007).
These studies provide clear evidence that ROS directly impact
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the contractile ability of the myocardium. Furthermore, it has
become apparent that the majority of channels involved in Ca2+
cycling are subject to oxidative modification.
The LTCC is the principal entry point of Ca2+ to the
cytoplasm therefore any alterations in its flux will directly impact
contraction. The α1c pore forming sub-unit of the LTCC is
subject to direct oxidation by redox agents causing a decrease
in peak Ca2+ entry (Gill et al., 1995; Fearon et al., 1999).
The large tetrameric SR Ca2+ release protein RyR2 contains
89 cysteines per subunit, approximately 21 of which can be
oxidized (Xu et al., 1998). Indeed, RyR2 immunoprecipitated
from failing human myocardium show increased levels of
oxidation and S-nitrosylation (Shan et al., 2010a). A graded
response of RyR2 activity, Ca2+ release, in response to ROS
exposure is reported and suggested as a fine-tuning mechanism
under physiological conditions which becomes aberrant during
excessive ROS exposure (Köhler et al., 2014). Importantly,
diastolic leak of Ca2+ is known to contribute to the formation
of Ca2+ waves, a precursor to the formation of lethal arrhythmic
delayed-after-depolarizations. In addition leak via RyR2 will
reduce SR Ca2+ content therefore attenuating cardiac inotropy.
SERCA is responsible for shuttling Ca2+ out of the cytoplasm and
into the SR. As such it is pivotal for determining the rate at which
the myocardium can relax and the amount of Ca2+ available for
subsequent contraction. Oxidation of SERCA at cysteine 674 is
well described (Scherer and Deamer, 1986; Lancel et al., 2010).
Treatment with oxidants or in vivo HF models inducing ROS
production decrease its activity slowing Ca2+ sequestration into
the SR (Qin et al., 2013, 2014). This reduces SR Ca2+ content and
slows relaxation, both of which are characteristic trademarks of
failing myocytes.
The activity of the NCX is observed to increase in HF
(Pogwizd et al., 1999). Theoretically, enhanced reverse mode
activity (Ca2+ influx to the cytoplasm) would be beneficial to
the failing myocardium as it would compensate for low levels
of systolic Ca2+. However, as the NCX also extrudes Ca2+
in exchange for Na+ its increased activity will introduce a
depolarizing current to the cytosol, a mechanism contributing
to the formation of arrhythmic delayed-after-depolarizations
(Despa and Bers, 2013). Various ROS increase NCX activity
(Reeves et al., 1986; Goldhaber, 1996; Kuster et al., 2010)
therefore in HF this may assist low systolic Ca2+ levels but
could also increase the propensity for arrhythmias. As with
Ca2+, a number of channels tightly regulate Na+ balance
within the myocardium. Through both ions’ interaction with
the NCX their fluctuations are tightly coupled to one another.
Nav1.5 contains multiple methionine residues which upon
oxidation dramatically slow its inactivation, prolonging Na+
influx (Kassmann et al., 2008). The key determinant of
intracellular Na+ is the Na+/K+-ATPase which itself is also
subject to inactivation by gluthathionylation of cysteine 46
(Figtree et al., 2009; Rasmussen et al., 2010). With ROS impacting
numerous Ca2+ and Na+ handling channels critical for cardiac
function it is clear that in heart failure their excess production
will have profound impacts on the hearts contractile and
electrical properties. Two kinases that can modulate the above
channels and are themselves susceptible to activation by ROS
are CaMKII and PKA, which are discussed in the following
sections.
Redox Regulation of CamKII within the
Myocardium
CaMKII is a ubiquitously expressed multimeric serine/threonine
kinase responsible for the phosphorylation of key ECC
proteins as well as regulating gene transcription associated with
pathological hypertrophy (Maier et al., 2003; Ai et al., 2005;
Wagner et al., 2006; Zhang et al., 2015). Transgenic mice
over expressing or lacking the predominant cardiac isoform
(δc) of CaMKII as well as select single point mutations to its
phosphorylation sites have implicated this kinase in diastolic
dysfunction, hypertrophy, and arrhythmogenesis (Maier et al.,
2003; Backs and Olson, 2006; Sossalla et al., 2011). These
mechanisms are principally driven through its interaction with
the critical Ca2+ handling proteins LTCC, RyR2, and PLB,
the net effect of which is the excess diastolic accumulation of
arrhythmogenic Ca2+ and Na+. CaMKII phosphorylation of
PLB mediates Ca2+ sequestration into the SR by relieving its
inhibitory effect on SERCA activity, thus potentially mitigating
the accumulation of excessive diastolic Ca2+ levels.
Each monomer of the dodecameric CaMKII multimer
associates via its C-terminal domain to form a double ringed
hexameric complex (Rellos et al., 2010). The catalytic N-terminal
of the kinase is responsible for substrate phosphorylation and
is connected to the C-terminal via the regulatory domain
(Rosenberg et al., 2005). Under basal conditions the regulatory
subunit of each monomer acts as substrate for its catalytic
counterpart. Additionally, the regulatory subunits flanking each
catalytic subunit block the binding of ATP or substrate. Thus,
under resting conditions the regulatory and catalytic domains
remain closely associated in an auto-inhibited state. Essential
to the activation of CaMKII is the binding of Ca2+ bound
calmodulin (Ca-CaM) to the regulatory domain, which occurs
under high intracellular Ca2+ concentrations. This induces a
conformational shift in the structure of the kinase which disrupts
the association between the regulatory and catalytic domains
allowing the catalytic subunit to phosphorylate its substrates.
Activation of CaMKII by Ca-CaM is dependent on local Ca2+
concentration as well as the frequency of Ca2+ release events
(De Koninck, 1998). High frequency oscillations in intracellular
Ca2+ concentration, as occurs during tachycardia, lead to inter-
subunit auto-phosphorylation at T287 (Erickson et al., 2011).
The impact of this is a more than 1000-fold increase in the
affinity of CaM for CaMKII (Meyer et al., 1992). Additionally, the
presence of phosphate prevents the re-association of the catalytic
and regulatory subunits thus maintaining the kinase in its active
conformation (Lai et al., 1987). Importantly, this auto-activity is
maintained even as Ca2+ levels return to basal conditions.
Initial reports showing CaMKII to be active under pro-
oxidant conditions such as during apoptosis led to the hypothesis
that the kinase may be subject to oxidative modification. Indeed,
CaMKII was found to remain active in myocytes in the presence
of H2O2 and angiotensin II (AngII) even after the addition of a
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Ca2+ chelator (Palomeque et al., 2009). Crystal structure analysis
of the kinase suggested that modification of methionine residues
M281 and M282, located on the regulatory subunit of the kinase
(Figure 3), may maintain the kinase in its active conformation,
similarly to T287 auto-phosphorylation (Rellos et al., 2010). In
support of this, an antibody generated to recognize dual sulfoxide
modified Met281/282 showed that mutation of Met282Val
completely inhibited the kinase’s activation by oxidation while
Met281Val partially attenuated this activation. In both cases pre-
activation of the kinase with Ca2+/calmodulin was necessary to
reveal the Met sites for modification. The application of AngII
both in vitro and in vivo increased M281/282 oxidation resulting
in apoptosis which was attenuated in M281/282Vmice (Erickson
et al., 2008). Similarly the cardiotoxic effects of aldosterone also
appear to be mediated via CaMKII oxidation. Chronic treatment
of mice with aldosterone following a myocardial infarction
led to increased CaMKII oxidation and subsequent promotion
of metalloproteinase 9, which was associated with increased
mortality and cardiac rupture (He et al., 2011). Transgenic mice
lackingMsrA are hyper-sensitized to CaMKII oxidation, myocyte
apoptosis and structural remodeling, following a myocardial
infarction while those over expressing it are protected from
aldosterone mediated cardiac rupture (Erickson et al., 2008; He
et al., 2011). The ability of oxidized CaMKII to interact with
LTCC and modulate Ca2+ influx may account for some of its
effects on the myocardium (Song et al., 2010).
Inflammation, an endogenous response triggered by tissue
damage, that occurs after a myocardial infarction and ischemia
reperfusion injury is associated with increased oxidative stress
and ROS production (Frantz et al., 2009). In an in vitro model
of myocyte inflammation using exposure to lipopolysaccharides
CaMKII oxidation and activity increased while inhibition of the
kinase lead to a reduction in the expression of pro-inflammatory
genes (Singh et al., 2009). This relationship was then explored
in vivo using myeloid differention protein 88 (MyD88) deficient
mice. MyD88−/− myocytes showed no increase in CaMKII
oxidation in response to lipopolysaccharide and were protected
against CaMKII oxidation, cardiac hypertrophy, inflammation,
apoptosis, and mortality following myocardial infarction (Singh
et al., 2012). This suggests MyD88 mediated CaMKII oxidation
may be an important regulator of cardiac hypertrophy and
inflammation.
Alteration in the balance and flux of ions critical for the
electrical stability of the heart, such as Ca2+ and Na+, fluctuate
during pathology thus impacting on the susceptibility to fatal
cardiac arrhythmias. Application of H2O2 to cardiac myocytes
increases oxidation of CaMKII, the incidence of pro-arrhythmic
Ca2+ sparks and late Na+ current leading to intracellular Na+
and Ca2+ overload (Wagner et al., 2011). Similarly, AngII was
seen to modulate the activity of both PKA and CaMKII in a
Nox2 dependent manner. This led to alterations in both Ca2+
and Na+ current which resulted in an increased propensity
for cellular arrhythmias (Wagner et al., 2014). Using a Na+
channel enhancer to induce intracellular Na+ overload, this was
observed to increase mitochondrial ROS production, CaMKII
oxidation and subsequent Ca2+ dysregulation (Viatchenko-
Karpinski et al., 2014). Indeed, levels of oxidized CaMKII are
seen to be elevated in atrial fibrillation patients compared to
those in sinus rhythm. In support of this mice infused with
AngII have increased susceptibility to atrial fibrillation which is
abolished in CaMKII oxidant-resistant (MM-VV) mice or those
over-expressing cardiac specific MsrA (Purohit et al., 2013).
Levels of oxidized CaMKII are significantly increased
in the pacemaker cells of diabetic patients following a
myocardial infarction (Luo et al., 2013). This was also
observed in pharmacologically induced diabetic mice receiving
a myocardial infarction and was associated with pace maker cell
apoptosis. Diabetic transgenic mice harboring CaMKII oxidant-
resistant mutations MM-VV were protected against myocardial
infarction, exhibiting reduced pace-maker cell apoptosis, heart
rate, and disease associated mortality (Luo et al., 2013). Recently,
CaMKII activation by O-linked N-acetlyglucosamine during
acute hyperglycaemia was reported. This modification was
observed in the hearts and brains of diabetic patients and rats
and associated with increased arrhythmogenesis (Erickson et al.,
2013). Therefore, a novel CaMKII- hyperglycaemia signaling
FIGURE 3 | CaMKII holoenzyme structure showing classical activation by autophosphorylation and oxidative activation by methionine sulfoxination. In
each instance binding of Ca2+/calmodulin (Ca-CaM) is necessary to first expose the regulatory domain.
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pathway may have potential implications in cardiac and diabetic
pathology.
A NO-dependent CaMKII activation pathway during
β-adrenergic stimulation has been proposed. In this study
β-adrenergic stimulation of cardiac myocytes increased NO
production which activated CaMKII independently of Ca2+
transients leading to increased Ca2+ spark frequency. These
findings were reproduced in the presence of GSNO and
attenuated with specific CaMKII inhibitors. Additionally,
S-nitrosylation of CaMKII was detectable using an antibody
specific to S-nitrosated cysteines (Gutierrez et al., 2013). Recently,
NO dependent S-nitrosylation of Cys280/289 has been shown to
activate CaMKII. This was specific for the CaMKIIα isoform and
dependent on S-nitrosylation of both Cys280 and 289 (Coultrap
and Bayer, 2014). This is important to note as CaMKIIδ, the
predominant cardiac isoform, lacks the homologous Cys280 of
CaMKIIα. The authors therefore speculate that the observed
increase in activation of cardiac CaMKII to NO donors in
earlier reports (Gutierrez et al., 2013), may be independent of
S-nitrosylation and instead due to other forms of oxidation
mediated by ONOO− production (Coultrap and Bayer, 2014).
Therefore, whether cross-talk between β-adrenergic and NO
signaling pathways have arrhythmogenic implications remains
to be seen.
Redox Regulation of PKA within the
Myocardium
PKA is a heterotetrameric threonine/serine kinase composed
of two regulatory and two catalytic subunits. The regulatory
subunits of PKA exist in two isoforms RI and RII, the
presence of either identifies its isozyme nomenclature as
PKARI or PKARII. On binding of two cAMP molecules to
the regulatory subunit the kinase undergoes a conformational
change that releases its catalytic subunits allowing substrate
phosphorylation. The regulatory subunits also contain an
N-terminal dimerization/docking domain that dictates its
localization via its interaction with A-kinase anchoring proteins
(AKAPs), thus providing a mechanism for compartmentalization
and specificity of PKA signaling (Kim et al., 2007).
Classically, PKA activation is modulated through the
sympathetic nervous system. Upon binding of epinephrine or
norepinephrine to G protein-coupled adrenergic receptors,
adenylate cyclases are activated producing a rapid increase in
intracellular cAMP. This rise in intracellular cAMP binds to the
regulatory subunits of PKA activating the kinase (Benovic et al.,
1988). The coupling of sympathetic innervation to intracellular
PKA activity is responsible for increasing the hearts ability to
adapt to higher energy demands such as in exercise and during
pathology. PKAmediates this through its modulation of key ECC
proteins to increase cardiac inotropy, lusitropy, and chronotropy
(Bers, 2002).
Activated PKA may phosphorylate the LTCC to increase
Ca2+ flux into the myoplasm (Hulme et al., 2003). However,
the proposed LTCC phosphorylation sites are under debate
(Hofmann et al., 2014). LTCC phosphorylation has been
proposed to potentiate the release of Ca2+ from the SR
through augmented CICR. Phosphorylation of troponin I by
activated PKA increases the rate of Ca2+ dissociation from
the myofilaments resulting in accelerated relaxation (lusitropy)
(Layland et al., 2005). In addition to facilitating SR Ca2+ release
PKA also augments Ca2+ sequestration into the SR by negatively
regulating the inhibitory effect of PLB on SERCA (Li et al., 2000).
This increased Ca2+ flux to the SR has the net effect of increasing
SR Ca2+ content, SR Ca2+ release, and SR Ca2+ re-uptake thus
PKA facilitates cardiac contraction, relaxation, and heart rate
when activated (Bers, 2002). PKA has been shown to critically
mediate RyR2 function via its specific S2808 phosphorylation
site (Lehnart et al., 2006; Wehrens et al., 2006). Transgenic
mice harboring a S2808A mutation show blunted inotropic and
chronotropic response to catecholamines (Shan et al., 2010b),
while phosphomimetic mutation of the receptor leads to age-
dependent cardiomyopathy and arrhythmias (Shan et al., 2010a).
Importantly, the activation of PKA can be induced
independently of cAMP by H2O2. This is through the formation
of two inter-protein disulfide bonds between the RIα subunits
(Figure 4) (Brennan et al., 2006). This bond was first identified
following a proteomic screen and results in the formation of an
anti-parallel dimer joined by two disulfides between Cys16 and
Cys37 (Zick and Taylor, 1982). This bond was initially thought
to be a constitutive modification due to the high concentration
of reducing agent required to break it (Leon et al., 1997). In later
studies the presence of disulfides within PKARI was evaluated
by Langendorff perfusing isolated rat hearts with increasing
concentrations of H2O2. These hearts were then homogenized
in the presence of the alkylating agent maleimide to prevent
artificial oxidation and PKARI resolved using SDS-PAGE in
the absence of reducing agent. By using this approach a dose
dependent increase in the percentage of disulfide bound RIα
could be observed in response to H2O2 which was entirely
abolished in the presence of reducing agent. Disulfide dimer
formation was associated with translocation of the kinase to
the myofilaments and phosphorylation of its targets troponin
I and myosin binding protein C. This resulted in enhanced
myocyte contractility independent of β-adrenergic stimulation
or elevations in cAMP and was inhibited in the presence of the
PKA inhibitor H89 (Brennan et al., 2006).
The translocation of disulfide bound PKARI to alternate
subcellular locations may be explained by redox mediated
changes in its affinity for AKAPs. Indeed, the cysteines which
form disulfides in response to H2O2 directly flank the area of
the regulatory subunit specifically responsible for AKAP binding.
Evidence for this interaction is supported by studies utilizing
mutant RIα with Cys17Ala or Cys37Ala which had 3 and 16
fold reductions respectively in their affinity for D-AKAP in
comparison to wild-type RIα (Sarma et al., 2010). Additionally,
it has been observed that the presence of PKA substrate itself can
catalyze the separation of the regulatory and catalytic subunits of
PKA (Vigil et al., 2005). This suggests a more intricate model of
PKA-AKAP interaction may be warranted and may also explain
how an increase in PKA substrate phosphorylation in response
to peroxide can be observed despite no alterations in intracellular
cAMP levels.
Additionally, nitro-cysteine (CysNO) can oxidize RIα
resulting in vasodilation independent of cAMP or NO signaling
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FIGURE 4 | PKA structure showing classical and oxidative
activation. Classical activation of PKA involves binding of cAMP
to the regulatory subunits of the kinase which induces a
conformational rearrangement releasing the catalytic subunits to
phosphorylate their target substrates. Oxidative activation doesn’t
involve the binding of cAMP. Instead two intermolecular disulfides
are formed between the regulatory subunits increasing their affinity
for their corresponding AKAP. Interaction with their binding partners
then brings PKA into proximity with its substrates, thus promoting
substrate induced activation.
pathways. Therefore, the activation of PKA by CysNO was
anticipated to exert positive inotropic effects on the myocardium.
However, this was not observed due to CysNO’s concurrent
oxidative activation of PKG1α which exerts a partial negative
inotropic effect on the myocardium (Burgoyne and Eaton,
2009).
Conclusion
The intracellular ROS environment is maintained through
alterations in oxidant producing enzymes, peroxidases, and
reducing proteins. Fluctuations in the redox status of biological
systems directly and indirectly alter protein structure and
function. Key mediators of cardiac physiological function
that are subject to oxidative-modification are the kinases
PKA and CaMKII. Oxidation of both kinases leads to
their activation therefore translating intercellular oxidative
fluctuations into phosphorylation-mediated signaling. Under
conditions of excessive oxidant production these signaling
pathways can become aberrant and may contribute to heart
failure progression. Failure to thoroughly understand the
precise chemical pathways underlying these changes may be
responsible for the disappointing results of long-term anti-
oxidant clinical trials. Full elucidation of the mechanisms
involving protein oxidation will allow for the development of
more specific therapies that may inhibit and/or cure cardiac
disease progression.
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